The bill to the Kremlin reaches as much as 2 billion rubles a day in incentives to recruit the 30,000 military volunteers it ...

New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers Fu ...

Meet a go-getter reaching well beyond the classroom and his chosen course of study to capitalize on diverse experiences. He ...

Indian Muslims today, unlike in the 1990s and 2000s, are firmly integrated with global Islamic issues, trends, and forces. In ...

The news got lost over draft weekend, but Penn State did finally land a proven receiver: Syracuse’s Trebor Pena, aka the guy ...

During the quarter, Immutep was granted two new patents for LAG525 in in the Philippines and the United States. Immutep was ...

Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced that the first participant has been dosed in the pivotal Phase 3 LUCIDITY clinical trial of avexitide, an investigational, ...

Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancerPatient recruitment ...

“—blues. Oh, no I might need this one. Can I check out a book?” ...

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") , a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, ...

ZW171 is a mesothelin (MSLN)-targeting TCE currently in a global Phase 1 clinical study (NCT06523803 ... Additionally, ...

The graduate forward — colloquially known as “Sit” by teammates and coaches — made an instant impact as a first-year, ...